Displaying 10 (all) recruiting clinical trials.
-
A PHASE 1 STUDY OF TJ033721 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS.
You can participate in this study if you are diagnosed with advanced solid tumors. The purpose of this study is to test the safety of ...Phase
Interventional
-
Randomized multicenter open-label phase 3 study of mirvetuximab soravtansine in combination with bevacizumab versus bevacizumab alone as maintenance therapy for patients with FRa-positive recurrent platinum-sensitive ovarian cancer
This study is designed for patients diagnosed with FRa-positive recurrent platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancers after second line platinum-based chemotherapy plus ...
Phase
Interventional
-
Compassionate Use of Pirtobrutinib for a Patient with Waldenstrom s macroglobulinemia.
You can participate in this study if you are diagnosed with Waldenstrom’s macroglobulinemia. In this study we will evaluate the study drug (Pirtobrutinib) for ...
Phase N/A Interventional
-
A Phase 1/2 Open-label Study to Investigate the Safety Efficacy and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults with Relapsed or Refractory B cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
This study is designed for patients diagnosed with relapsed or refractory B cell precursor acute lymphoblastic leukemia (R/R B-ALL).
This study is a 2-part ...
Phase
Interventional
-
A PHASE 3 RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND MULTICENTER TRIAL OF SELINEXOR IN MAINTENANCE THERAPY AFTER SYSTEMIC THERAPY FOR PATIENTS WITH P53 WILD-TYPE ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA
This is a study to test a drug called selinexor for patients with EC (endometrial carcinoma). The drug will be given to patients who have ...
Phase
Interventional
-
A Phase I Open-label Multi-center Clinical Study to Evaluate Safety Tolerability Pharmacokinetics Pharmacodynamics and Preliminary Anti-Tumor Activity of AC176 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) Who Have Progressed on at Least Two Prior Systemic Therapies
This study is designed for patients diagnosed with metastatic castration resistant prostate cancer (mCRPC).
This is a Phase I, first-in-human, open-label, multi-center dose-escalation study of ...
Phase
Interventional
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test Age group both International Study of Comparative Health Effectiveness with Medical and Invasive Approaches
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
-
Test New Study Notification
The objective of the ISCHEMIA study is to determine the best management strategy for patients with stable ischemic heart disease and at least moderate ischemia ...Phase
